Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Scientists at Centers for Disease Control and Prevention detail research in cancer vaccines
December 16th, 2008
Researchers detail in 'Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role,' new data in cancer. According to recent research from the United States, "The recent US Food and Drug Administration licensure of a prophylactic vaccine against oncogenic human papillomavirus (HPV) types 16 and 18, the first of its kind, poses unique challenges in postmarketing vaccine surveillance, especially in measuring vaccine effectiveness against biologic endpoints of HPV infection. Historically, the national system of population-based cancer registries in the US has provided high-quality data on cancer incidence and mortality for the most important...
Source: Cancer Weekly (2008-12-16)
|
